FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations is a research paper published in Digestive Diseases and Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DP2 Award CA195764
National Cancer Institute
Grant: K12 award CA090628
National Cancer Institute
Grant: K01 award CA234324
SPORE
Grant: SPORE Project Award 5P50CA210964-03
SPORE
Grant: SPORE Supplement Award 3P50CA210964-02S1
NCI NIH HHS
Grant: DP2 CA195764
NCI NIH HHS
Grant: K01 CA234324
NCI NIH HHS
Grant: K12 CA090628
NCI NIH HHS
Grant: P50 CA210964
National Institutes of Health
Grant: 5K12CA090628-25
Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic
National Institutes of Health
Grant: 1DP2CA195764-01
Oncolytic Virotherapy in Hepatocellular Cancer
National Institutes of Health
Grant: 5P50CA210964-03
Mayo Clinic Hepatobiliary SPORE
National Institutes of Health
Grant: 7K01CA234324-04
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals